project id: TCGA-THCA; case submitter id: TCGA-DE-A0Y3; selected normal wgs: true; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 8.7; spectrophotometer method: UV Spec; age at index: 60; days to birth: -22239; ethnicity: not hispanic or latino; gender: female; race: asian; vital status: Alive; year of birth: 1948; age at diagnosis: 22239; ajcc pathologic m: M1; ajcc pathologic n: N1b; ajcc pathologic stage: Stage IVC; ajcc pathologic t: T4a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1526.0; icd 10 code: C73; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Thyroid gland; synchronous malignancy: No; tissue or organ of origin: Thyroid gland; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 885; days to sample procurement: 0; initial weight: 20.0; portion submitter id: TCGA-DE-A0Y3-01B-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0; percent tumor nuclei: 99.0;